Theranos Investor Conference Presentation Deck

Molecular Biology: NAA Zika Assay with Capillary Whole Blood is consistent with Comparators Negative percent agreement Positive percent agreement NAA/ CDC & altona 56/56 Capillary LoD = 320 copies/mL 50/51 Capillary whole blood, venous serum, and urine (n = 107) 77 from US (apparently healthy) 30 from the Dominican Republic (Zika symptomatic) Percent Agreement 100% This technology has not been cleared or approved by the FDA and is not for sale in the United States. 98% 95% Confidence Interval [93.6, 100.0]% [89.7, 99.7]% theranos 73

View entire presentation